We are live on ! Find out more
AP

AtonRa Partners Portfolio holdings

AUM $50.2M
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
+4.01%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
10 Year Est. Return
AUM
$299M
AUM Growth
+$26.5M
Cap. Flow
+$30.1M
Cap. Flow %
10.07%
Top 10 Hldgs %
22.19%
Holding
118
New
6
Increased
104
Reduced
5
Closed
3

Top Buys

Rank Stock Value
1
LSPD icon
Lightspeed Commerce
LSPD
+$5.25M
2
DSGX icon
Descartes Systems
DSGX
+$3.03M
3
LEGN icon
Legend Biotech
LEGN
+$1.39M
4
BRKR icon
Bruker
BRKR
+$1.25M
5
RKLB icon
Rocket Lab Corp
RKLB
+$1.2M

Top Sells

Rank Stock Value
1
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.31M
2
BNTX icon
BioNTech
BNTX
+$1.14M
3
MNTS icon
Momentus
MNTS
+$928K
4
MCRB icon
Seres Therapeutics
MCRB
+$843K
5
ABT icon
Abbott
ABT
+$798K

Sector Composition

Rank Sector Weight
1 Technology 46.29%
2 Healthcare 31.99%
3 Financials 9.06%
4 Industrials 6.13%
5 Consumer Discretionary 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKLB icon
76
Rocket Lab Corp
RKLB
$39.9B
$1.6M 0.54%
+99,422
New +$1.2M
AXNX
77
DELISTED
Axonics, Inc. Common Stock
AXNX
$1.6M 0.54%
24,607
+3,389
+16% +$231K
OKTA icon
78
Okta
OKTA
$24.1B
$1.59M 0.53%
6,705
+488
+8% +$121K
TRMB icon
79
Trimble
TRMB
$12.3B
$1.57M 0.53%
19,115
+997
+6% +$87.6K
ABT icon
80
Abbott
ABT
$180B
$1.54M 0.52%
13,080
-6,500
-33% -$798K
RPD icon
81
Rapid7
RPD
$634M
$1.53M 0.51%
13,565
+592
+5% +$67.1K
TWST icon
82
Twist Bioscience
TWST
$5.62B
$1.47M 0.49%
13,769
+1,848
+16% +$212K
SGEN
83
DELISTED
Seagen Inc. Common Stock
SGEN
$1.36M 0.45%
8,002
+732
+10% +$114K
VRNS icon
84
Varonis Systems
VRNS
$5.25B
$1.35M 0.45%
22,271
+1,390
+7% +$87.1K
MAXR
85
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$1.28M 0.43%
45,122
+3,512
+8% +$113K
BPMC
86
DELISTED
Blueprint Medicines
BPMC
$1.26M 0.42%
12,238
+841
+7% +$78.3K
BAH icon
87
Booz Allen Hamilton
BAH
$8.7B
$1.25M 0.42%
15,810
+803
+5% +$67.1K
TDY icon
88
Teledyne Technologies
TDY
$30.4B
$1.21M 0.4%
2,818
+163
+6% +$72K
NOW icon
89
ServiceNow
NOW
$102B
$1.21M 0.4%
9,720
+615
+7% +$74.5K
NRIX icon
90
Nurix Therapeutics
NRIX
$2.43B
$1.21M 0.4%
40,212
+16,601
+70% +$512K
FIS icon
91
Fidelity National Information Services
FIS
$21.5B
$1.2M 0.4%
9,861
+1,559
+19% +$209K
BRKR icon
92
Bruker
BRKR
$9.2B
$1.18M 0.39%
+15,067
New +$1.25M
NBIX icon
93
Neurocrine Biosciences
NBIX
$17.7B
$1.13M 0.38%
11,818
+915
+8% +$86.4K
ZBRA icon
94
Zebra Technologies
ZBRA
$12.4B
$1.09M 0.36%
2,110
+137
+7% +$76.3K
EXAS
95
DELISTED
Exact Sciences
EXAS
$1.07M 0.36%
11,242
+1,473
+15% +$156K
IRDM icon
96
Iridium Communications
IRDM
$4.85B
$1.04M 0.35%
26,101
+1,822
+8% +$76.5K
BL icon
97
BlackLine
BL
$1.69B
$1.03M 0.35%
8,753
+174
+2% +$20K
RARE icon
98
Ultragenyx Pharmaceutical
RARE
$2.65B
$974K 0.33%
10,803
+638
+6% +$57.7K
MANT
99
DELISTED
Mantech International Corp
MANT
$958K 0.32%
12,618
+567
+5% +$46.4K
COHR icon
100
Coherent
COHR
$55.2B
$943K 0.32%
15,888
+839
+6% +$54.8K

Similar funds

AtonRa Partners's Q3 2021 Portfolio in Review

As of Q3 2021, AtonRa Partners held 118 positions worth $299M, up 9.7% from $273M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

AtonRa Partners deployed $30.1M of net new capital in Q3 2021, opening 6 new positions and adding to 104 existing holdings. Its largest new stake was Lightspeed Commerce: 52,877 shares worth $5.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 44% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was BioNTech, an estimated $1.14M trimmed.

  • AtonRa Partners's largest Q3 2021 buy was Lightspeed Commerce: 52,877 shares worth $5.1M.
  • AtonRa Partners added most to Pacific Biosciences in Q3 2021, an estimated $1.08M increase.
  • AtonRa Partners's biggest Q3 2021 reduction was BioNTech, cutting an estimated $1.14M.
  • AtonRa Partners fully exited Acadia Pharmaceuticals in Q3 2021, selling an estimated $1.31M.
  • AtonRa Partners's ten largest holdings make up 22% of its $299M portfolio in Q3 2021.
  • AtonRa Partners opened 6 new positions and closed 3 in Q3 2021.
  • AtonRa Partners's portfolio value rose 9.7% quarter-over-quarter to $299M.

Based on AtonRa Partners's 13F filing for Q3 2021, filed 15 Nov 2021.